During the past decade, University of Florida Hepatology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 8 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Florida Hepatology" #1 sponsor was "Bristol-Myers Squibb" with 4 trials, followed by "University of Florida" with 2 trials sponsored, "Bausch Health Americas, Inc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Romark Laboratories L.C." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Florida Hepatology" #1 collaborator was "Otsuka America Pharmaceutical" with 1 trials as a collaborator, "Pharmasset" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Florida Hepatology" are "Chronic Hepatitis C" (2 trials), "Cirrhosis" (2 trials), "Hepatitis C Virus" (2 trials), "Ascites" (1 trials) and "Biliary Cirrhosis, Primary" (1 trials). Many other conditions were trialed in "University of Florida Hepatology" in a lesser frequency.

Most popular intervention types in "University of Florida Hepatology" are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daclatasvir" (3 trials), "Placebo" (3 trials), "Ribavirin" (2 trials), "Sofosbuvir" (2 trials) and "ribavirin" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Florida Hepatology" are 10 trials for "All" genders.

Currently, there are NaN active trials in "University of Florida Hepatology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in University of Florida Hepatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Florida Hepatology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".